← FDA Drug Approvals (Drugs@FDA)

DEFLAZACORT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2024-11-05

Drug application

FDA Application #

ANDA216720

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFLAZACORT

Generic name

DEFLAZACORT

Active ingredients

DEFLAZACORT

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

UPSHER SMITH LABS

Manufacturer

Upsher-Smith Laboratories, LLC

First approval

2024-11-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown